- Home
- PAPL vs NBY Comparison
PAPL vs NBY Comparison
Compare PAPL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- NBY
- Stock Information
- Founded
- PAPL 2015
- NBY 2000
- Country
- PAPL Canada
- NBY United States
- Employees
- PAPL N/A
- NBY N/A
- Industry
- PAPL Finance: Consumer Services
- NBY
- Sector
- PAPL Finance
- NBY
- Exchange
- PAPL Nasdaq
- NBY Nasdaq
- Market Cap
- PAPL 2.8M
- NBY 3.4M
- IPO Year
- PAPL 2023
- NBY 2007
- Fundamental
- Price
- PAPL $0.11
- NBY $0.57
- Analyst Decision
- PAPL Strong Buy
- NBY Strong Buy
- Analyst Count
- PAPL 2
- NBY 1
- Target Price
- PAPL $5.25
- NBY $0.85
- AVG Volume (30 Days)
- PAPL 2.7M
- NBY 48.3K
- Earning Date
- PAPL 04-14-2025
- NBY 05-20-2025
- Dividend Yield
- PAPL N/A
- NBY N/A
- EPS Growth
- PAPL N/A
- NBY N/A
- EPS
- PAPL N/A
- NBY N/A
- Revenue
- PAPL $2,848,365.00
- NBY $9,781,000.00
- Revenue This Year
- PAPL $7.18
- NBY $23.91
- Revenue Next Year
- PAPL $25.02
- NBY $32.05
- P/E Ratio
- PAPL N/A
- NBY N/A
- Revenue Growth
- PAPL 13.01
- NBY N/A
- 52 Week Low
- PAPL $0.11
- NBY $0.36
- 52 Week High
- PAPL $2.10
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- PAPL 18.51
- NBY 46.61
- Support Level
- PAPL $0.11
- NBY $0.52
- Resistance Level
- PAPL $0.15
- NBY $0.64
- Average True Range (ATR)
- PAPL 0.03
- NBY 0.03
- MACD
- PAPL -0.01
- NBY 0.00
- Stochastic Oscillator
- PAPL 5.21
- NBY 41.83
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.